Propylthiouracil

| Apr 27, 2010

[Updated 04/21/2010] FDA added a Boxed Warning to the label for propylthiouracil,to include information about reports of severe liver injury and acute liver failure, some of which have been fatal, in adult and pediatric patients.

Related Posts:

  1. Orlistat (marketed as Alli and Xenical): Labeling Change
  2. Plavix (clopidogrel): Reduced effectiveness in patients who are poor metabolizers of the drug
  3. ADA on Zinc in Denture Cream
  4. Cleviprex (clevidipine butyrate): Recall
  5. Benicar (olmesartan): Ongoing Safety Review

Filed Under: Dangerous Drugs